Skip to main content

menu
Pediatrics / Hematology/Oncology Division / Research Publications
 

Research Publications

    1. Gorfinkel L
    2. Raghunandan S
    3. Watkins B
    4. Hebert K
    5. Neuberg DS
    6. Bratrude B
    7. Betz K
    8. Yu A
    9. Choi SW
    10. Davis J
    11. Duncan C
    12. Giller R
    13. Grimley M
    14. Harris AC
    15. Jacobsohn D
    16. Lalefar N
    17. Farhadfar N
    18. Pulsipher MA
    19. Shenoy S
    20. Petrovic A
    21. Schultz KR
    22. Yanik GA
    23. Blazar BR
    24. Horan JT
    25. Langston A
    26. Kean LS
    27. Qayed M
    Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD.; Bone marrow transplantation. 2024 Feb 21.
    1. Rossmann MP
    2. Palis J
    Developmental regulation of primitive erythropoiesis.; Current opinion in hematology. 2024 Feb 12.
    1. McGrath KE
    2. Koniski AD
    3. Murphy K
    4. Getman M
    5. An HH
    6. Schulz VP
    7. Kim AR
    8. Zhang B
    9. Schofield TL
    10. Papoin J
    11. Blanc L
    12. Kingsley PD
    13. Westhoff CM
    14. Gallagher PG
    15. Chou ST
    16. Steiner LA
    17. Palis J
    BMI1 regulates human erythroid self-renewal through both gene repression and gene activation.; bioRxiv : the preprint server for biology. 2024 Feb 06.
    1. Lo AC
    2. Liu A
    3. Liu Q
    4. Yasui Y
    5. Castellino SM
    6. Kelly KM
    7. Hererra AF
    8. Friedberg JW
    9. Friedman DL
    10. Schwartz CL
    11. Pei Q
    12. Kessel S
    13. Bergeron-Gravel S
    14. Dama H
    15. Roberts K
    16. Constine LS
    17. Hodgson DC
    Late Cardiac Toxic Effects Associated With Treatment Protocols for Hodgkin Lymphoma in Children.; JAMA network open; Vol 7(1), pp. e2351062. 2024 Jan 02.
    1. Milano MT
    2. Marks LB
    3. Olch AJ
    4. Yorke ED
    5. Jackson A
    6. Bentzen SM
    7. Constine LS
    Comparison of Risks of Late Effects From Radiation Therapy in Children Versus Adults: Insights From the QUANTEC, HyTEC, and PENTEC Efforts; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Nanda RH
    2. Hua CH
    3. Flampouri S
    4. Eaton B
    5. Kaste S
    6. Patni T
    7. Ronckers C
    8. Constine LS
    9. Marks LB
    10. Esiashvili N
    Risks of Spinal Abnormalities and Growth Impairment After Radiation to the Spine in Childhood Cancer Survivors: A PENTEC Comprehensive Review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Hua CH
    2. Bentzen SM
    3. Li Y
    4. Milano MT
    5. Rancati T
    6. Marks LB
    7. Constine LS
    8. Yorke ED
    9. Jackson A
    Improving Pediatric Normal Tissue Radiation Dose-Response Modeling in Children With Cancer: A PENTEC Initiative .; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Ajithkumar T
    2. Avanzo M
    3. Yorke E
    4. Tsang DS
    5. Milano MT
    6. Olch AJ
    7. Merchant TE
    8. Dieckmann K
    9. Mahajan A
    10. Fuji H
    11. Paulino AC
    12. Timmermann B
    13. Marks LB
    14. Bentzen SM
    15. Jackson A
    16. Constine LS
    Brain and Brain Stem Necrosis After Reirradiation for Recurrent Childhood Primary Central Nervous System Tumors: A PENTEC Comprehensive Review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Cooper BT
    2. Mayo CS
    3. Milano MT
    4. Olch AJ
    5. Oh C
    6. Keating GF
    7. Hallstrom A
    8. Constine LS
    9. Laack NN
    Predictive Factors Associated With Radiation Myelopathy in Pediatric Patients With Cancer: A PENTEC Comprehensive Review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Bates JE
    2. Marples B
    3. Hudson MM
    4. Williams AM
    5. Marcus K
    6. Howell R
    7. Paulino A
    8. Constine LS
    PENTEC: Biodevelopmental Considerations in Pediatric Patients with Cancer and Childhood Cancer Survivors; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Constine LS
    2. Marks LB
    3. Milano MT
    4. Ronckers CM
    5. Jackson A
    6. Hudson MM
    7. Marcus KJ
    8. Hodgson DC
    9. Hua CH
    10. Howell RM
    11. Marples B
    12. Yorke E
    13. Olch A
    14. Bentzen SM
    A User's Guide and Summary of Pediatric Normal Tissue Effects in the Clinic (PENTEC): Radiation Dose-Volume Response for Adverse Effects After Childhood Cancer Therapy and Future Directions; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Lo AC
    2. Liu A
    3. Liu Q
    4. Yasui Y
    5. Castellino SM
    6. Kelly KM
    7. Hererra AF
    8. Friedberg JW
    9. Friedman DL
    10. Schwartz CL
    11. Pei Q
    12. Kessel S
    13. Bergeron-Gravel S
    14. Dama H
    15. Roberts K
    16. Constine LS
    17. Hodgson DC
    Cardiac Toxicity Associated with Treatment Protocols for Hodgkin Lymphoma in Children; JAMA Network Open; Vol in press. 2024 Jan 01.
    1. Murphy B
    2. Jackson A
    3. Bass JK
    4. Tsang DS
    5. Ronckers CM
    6. Kremer L
    7. Baliga S
    8. Olch A
    9. Zureick AH
    10. Jee KW
    11. Constine LS
    12. Yock TI
    Modeling the risk of hearing loss from radiation therapy in childhood cancer survivors: a PENTEC comprehensive review .; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Hill-Kayser C
    2. Yorke E
    3. Jackson A
    4. Gracia C
    5. Ginsberg J
    6. Keene K
    7. Ronckers C
    8. Metzger ML
    9. Li Z
    10. Constine L
    11. Hua CH
    Effects of radiation therapy on the female reproductive tract in childhood cancer survivors: a PENTEC comprehensive review .; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Baliga S
    2. Patel S
    3. Naqa IE
    4. Li XA
    5. Cohen LE
    6. Howell RM
    7. Hoppe BS
    8. Constine LS
    9. Palmer JD
    10. Hamstra D
    11. Olch AJ
    Testicular dysfunction in male childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Casey DL
    2. Vogelius IR
    3. Brodin NP
    4. Roberts KB
    5. Avanzo M
    6. Moni J
    7. Owens C
    8. Ronckers CM
    9. Constine LS
    10. Bentzen SM
    11. Olch A
    Risk of subsequent neoplasms in childhood cancer survivors after radiation therapy: a comprehensive PENTEC review .; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Shen CJ
    2. Kry SF
    3. Buchsbaum JC
    4. Milano MT
    5. Inskip PD
    6. Ulin K
    7. Francis JH
    8. Wilson MW
    9. Whelan KF
    10. Mayo CS
    11. Olch AJ
    12. Constine LS
    13. Terezakis SA
    14. Vogelius IR
    Retinopathy, optic neuropathy, and cataract in childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Hall MD
    2. Howell RM
    3. Jackson A
    4. Owens CA
    5. Hernandez S
    6. Castellino SM
    7. Ronckers CM
    8. Constine LS
    9. Bradley JA
    Liver late effects in childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review .; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Poppe MM
    2. Tai A
    3. Li XA
    4. Miften M
    5. Olch A
    6. Marks LB
    7. Qureshi BM
    8. Spunt SL
    9. Shnorhavorian M
    10. Nelson G
    11. Ronckers C
    12. Kalapurakal J
    13. Marples B
    14. Constine LS
    15. Liu AK
    Kidney disease in childhood cancer survivors treated with radiation therapy: a comprehensive PENTEC genitourinary review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Wheeler G
    2. Grassberger C
    3. Samers J
    4. Dwyer M
    5. Wiltshire K
    6. Daly P
    7. Alvarez B
    8. Campbell BA
    9. Kerr AJ
    10. Kron T
    11. Duane FK
    12. Zacharin M
    13. Downie P
    14. Kyriakou E
    15. Ronckers CM
    16. Constine LS
    17. Hiniker SM
    Central endocrine complications among childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review .; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Bates JE
    2. Rancati T
    3. Keshavarz H
    4. Gagliardi G
    5. Aznar MC
    6. Howell RM
    7. Shrestha S
    8. Moiseenko V
    9. Yorke E
    10. Armenian S
    11. Kremer L
    12. Chen MH
    13. van der PH
    14. Cutter DJ
    15. Constine LS
    16. Hodgson D
    Cardiac disease in childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Ehler ED
    2. Turcotte LM
    3. Skamene S
    4. Baker KS
    5. Das SK
    6. Constine LS
    7. Yuan J
    8. Dusenbery KE
    Idiopathic pneumonitis syndrome after total body irradiation in pediatric patients undergoing myeloablative hematopoietic stem cell transplantation: a PENTEC comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Waxer JF
    2. Wong K
    3. Modiri A
    4. Charpentier AM
    5. Moiseenko V
    6. Ronckers CM
    7. Taddei PJ
    8. Constine LS
    9. Sprow G
    10. Tamrazi B
    11. MacDonald S
    12. Olch AJ
    Risk of cerebrovascular events among childhood and adolescent patients receiving cranial radiation therapy: a Pediatric Normal Tissue Effects in the Clinic normal tissue outcomes comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Milgrom SA
    2. van Luijk P
    3. Pino R
    4. Ronckers CM
    5. Kremer LC
    6. Gidley PW
    7. Grosshans DR
    8. Laskar S
    9. Okcu MF
    10. Constine LS
    11. Paulino AC
    Salivary and Dental Complications in Childhood Cancer Survivors Treated With Radiation Therapy to the Head and Neck: A Pediatric Normal Tissue Effects in the Clinic (PENTEC) Comprehensive Review .; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Lo AC
    2. Ronckers C
    3. Aznar MC
    4. Avanzo M
    5. van Dijk I
    6. Kremer L
    7. Gagliardi G
    8. Howell RM
    9. Rancati T
    10. Constine LS
    11. Marcus KJ
    Breast hypoplasia and decreased lactation from radiation therapy in survivors of pediatric malignancy: a PENTEC comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Mahajan A
    2. Stavinoha PL
    3. Rongthong W
    4. Brodin NP
    5. McGovern SL
    6. El NI
    7. Palmer JD
    8. Vennarini S
    9. Indelicato DJ
    10. Aridgides P
    11. Bowers DC
    12. Kremer L
    13. Ronckers C
    14. Constine L
    15. Avanzo M
    Neurocognitive effects and necrosis in childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Briere TM
    2. Agrusa JE
    3. Martel MK
    4. Jackson A
    5. Olch AJ
    6. Ronckers CM
    7. Kremer L
    8. Constine LS
    9. McAleer MF
    Acute and Late Pulmonary Effects After Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Milano MT
    2. Vargo JA
    3. Yorke ED
    4. Ronckers CM
    5. Kremer LC
    6. Chafe S
    7. van Santen HM
    8. Marks LB
    9. Bentzen SM
    10. Constine LS
    11. Vogelius IR
    Primary hypothyroidism in childhood cancer survivors treated with radiotherapy: A PENTEC comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Constine LS
    2. Olch AJ
    3. Jackson A
    4. Hua CH
    5. Ronckers C
    6. Milano MT
    7. Marcus KJ
    8. Yorke E
    9. Hodgson D
    10. Howell R
    11. Hudson M
    12. Williams J
    13. Marples B
    14. Kremer L
    15. Marks LB
    16. Bentzen SM
    Pediatric Normal Tissue Effects in the Clinic (PENTEC): an international collaboration to assess normal tissue radiation dose-volume-response relationships for children with cancer; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
    1. Lv X
    2. Murphy K
    3. Murphy Z
    4. Getman MR
    5. Rahman NF
    6. Nakamura Y
    7. Blanc L
    8. Gallagher PG
    9. Palis J
    10. Mohandas N
    11. Steiner LA
    HEXIM1 is an Essential Transcription Regulator During Human Erythropoiesis.; Blood. 2023 Sep 22.
    1. Wang Y
    2. Ronckers CM
    3. van Leeuwen FE
    4. Moskowitz CS
    5. Leisenring W
    6. Armstrong GT
    7. de Vathaire F
    8. Hudson MM
    9. Kuehni CE
    10. Arnold MA
    11. Demoor-Goldschmidt C
    12. Green DM
    13. Henderson TO
    14. Howell RM
    15. Ehrhardt MJ
    16. Neglia JP
    17. Oeffinger KC
    18. van der Pal HJH
    19. Robison LL
    20. Schaapveld M
    21. Turcotte LM
    22. Waespe N
    23. Kremer LCM
    24. Teepen JC
    Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer.; Nature medicine; Vol 29(9), pp. 2268-2277. 2023 Sep 11.
    1. Raghunandan S
    2. Gorfinkel L
    3. Graiser M
    4. Bratrude B
    5. Suessmuth Y
    6. Gillespie S
    7. Westbrook AL
    8. Williams KM
    9. Schoettler ML
    10. Kean LS
    11. Horan J
    12. Langston AA
    13. Qayed M
    14. Watkins B
    Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis.; Blood advances; Vol 7(16), pp. 4395-4399. 2023 Aug 22.
    1. Goh I
    2. Botting RA
    3. Rose A
    4. Webb S
    5. Engelbert J
    6. Gitton Y
    7. Stephenson E
    8. Quiroga Londoño M
    9. Mather M
    10. Mende N
    11. Imaz-Rosshandler I
    12. Yang L
    13. Horsfall D
    14. Basurto-Lozada D
    15. Chipampe NJ
    16. Rook V
    17. Lee JTH
    18. Ton ML
    19. Keitley D
    20. Mazin P
    21. Vijayabaskar MS
    22. Hannah R
    23. Gambardella L
    24. Green K
    25. Ballereau S
    26. Inoue M
    27. Tuck E
    28. Lorenzi V
    29. Kwakwa K
    30. Alsinet C
    31. Olabi B
    32. Miah M
    33. Admane C
    34. Popescu DM
    35. Acres M
    36. Dixon D
    37. Ness T
    38. Coulthard R
    39. Lisgo S
    40. Henderson DJ
    41. Dann E
    42. Suo C
    43. Kinston SJ
    44. Park JE
    45. Polanski K
    46. Marioni J
    47. van Dongen S
    48. Meyer KB
    49. de Bruijn M
    50. Palis J
    51. Behjati S
    52. Laurenti E
    53. Wilson NK
    54. Vento-Tormo R
    55. Chédotal A
    56. Bayraktar O
    57. Roberts I
    58. Jardine L
    59. Göttgens B
    60. Teichmann SA
    61. Haniffa M
    Yolk sac cell atlas reveals multiorgan functions during human early development.; Science (New York, N.Y.); Vol 381(6659), pp. eadd7564. 2023 Aug 18.
    1. Raghunandan S
    2. Gorfinkel L
    3. Bratrude B
    4. Suessmuth Y
    5. Hebert K
    6. Neuberg D
    7. Williams KM
    8. Schoettler ML
    9. Langston AA
    10. Kean LS
    11. Qayed M
    12. Horan J
    13. Watkins BK
    Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis.; Bone marrow transplantation. 2023 Aug 14.
    1. Raghunandan S
    2. Qayed M
    3. Watkins BK
    4. Graiser M
    5. Gorfinkel L
    6. Westbrook A
    7. Gillespie S
    8. Bratrude B
    9. Petrovic A
    10. Suessmuth Y
    11. Horan J
    12. Kean LS
    13. Langston AA
    Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies.; Bone marrow transplantation. 2023 Aug 14.
    1. Bourne JH
    2. Campos J
    3. Hopkin SJ
    4. Whitworth K
    5. Palis J
    6. Senis YA
    7. Rayes J
    8. Iqbal AJ
    9. Brill A
    Megakaryocyte NLRP3 hyperactivation induces mild anemia and potentiates inflammatory response in mice.; Frontiers in immunology; Vol 14, pp. 1226196. 2023 Aug 09.
    1. Takahashi T
    2. Al-Kofahi M
    3. Jaber M
    4. Bratrude B
    5. Betz KM
    6. Suessmuth Y
    7. Yu A
    8. Neuberg DS
    9. Choi SW
    10. Davis JH
    11. Duncan C
    12. Giller RH
    13. Grimley M
    14. Harris AC
    15. Jacobsohn DA
    16. Lalefar NR
    17. Farhadfar N
    18. Pulsipher MA
    19. Shenoy S
    20. Petrovic A
    21. Schultz KR
    22. Yanik GA
    23. Blazar BR
    24. Horan JT
    25. Watkins B
    26. Langston A
    27. Qayed M
    28. Kean LS
    Higher Abatacept Exposure Decreases Acute GVHD Risk Without Increasing Adverse Events.; Blood. 2023 Jun 15.
    1. Noronha SA
    2. Strouse JJ
    Fever in Children With Sickle Cell Disease-Rethinking the Approach When Bacteremia Is Rare.; JAMA network open; Vol 6(6), pp. e2318837. 2023 Jun 01.
    1. Stenger EO
    2. Watkins B
    3. Rogowski K
    4. Chiang KY
    5. Haight A
    6. Leung K
    7. Qayed M
    8. Raghunandan S
    9. Suessmuth Y
    10. Kean L
    11. Horan J
    Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure.; Blood advances; Vol 7(10), pp. 2196-2205. 2023 May 23.
    1. Devine KJ
    2. Fries C
    3. Hermiston M
    4. Wistinghausen B
    How I approach B-lymphoblastic lymphoma in children.; Pediatric blood & cancer. 2023 May 09.
    1. Maurya P
    2. Ture SK
    3. Li C
    4. Scheible KM
    5. McGrath KE
    6. Palis J
    7. Morrell CN
    Transfusion of Adult, but Not Neonatal, Platelets Promotes Monocyte Trafficking in Neonatal Mice.; Arteriosclerosis, thrombosis, and vascular biology. 2023 Mar 23.
    1. Farris N
    2. Benoit SW
    3. McNinch NL
    4. Bodas P
    Urinary Biomarkers for the Assessment of Acute Kidney Injury of Pediatric Sickle Cell Anemia Patients Admitted for Severe Vaso-occlusive Crises.; Journal of pediatric hematology/oncology; Vol 45(6), pp. 309-314. 2023 Feb 20.
    1. Buoninfante OA
    2. Pilzecker B
    3. Spanjaard A
    4. de Groot D
    5. Prekovic S
    6. Song JY
    7. Lieftink C
    8. Ayidah M
    9. Pritchard CEJ
    10. Vivié J
    11. Mcgrath KE
    12. Huijbers IJ
    13. Philipsen S
    14. von Lindern M
    15. Zwart W
    16. Beijersbergen RL
    17. Palis J
    18. van den Berk PCM
    19. Jacobs H
    Mammalian life depends on two distinct pathways of DNA damage tolerance.; Proceedings of the National Academy of Sciences of the United States of America; Vol 120(4), pp. e2216055120. 2023 Jan 20.
    1. Papoin J
    2. Yan H
    3. Leduc M
    4. Le Gall M
    5. Narla A
    6. Palis J
    7. Steiner LA
    8. Gallagher PG
    9. Hillyer CD
    10. Gautier EF
    11. Mohandas N
    12. Blanc L
    Phenotypic and proteomic characterization of the human erythroid progenitor continuum reveal dynamic changes in cell cycle and in metabolic pathways.; American journal of hematology. 2023 Jan 06.
    1. Reilly M
    2. Dandapani SV
    3. Kumar KA
    4. Constine L
    5. Fogh SE
    6. Roberts KB
    7. Small WJ
    8. Schechter NR
    ACR-ARS practice parameter for the performance of total body irradiation; Am J Clin Oncol; Vol 46(5), pp. 185-192. 2023 Jan 01.
    1. Gutkin PM
    2. Skinner L
    3. Jiang A
    4. Donaldson SS
    5. Loo BJ
    6. Oh J
    7. Wang YP
    8. von ER
    9. Snyder J
    10. Bredfeldt JS
    11. Breneman JC
    12. Constine LS
    13. Faught AM
    14. Haas-Kogan D
    15. Holmes JA
    16. Krasin M
    17. Larkin C
    18. Marcus KJ
    19. Maxim PG
    20. McClelland S
    21. rd MB
    22. Palmer JD
    23. Perkins SM
    24. Shen CJ
    25. Terezakis S
    26. Bush K
    27. Hiniker SM
    Feasibility of the Audio-Visual Assisted Therapeutic Ambience in Radiotherapy (AVATAR) System for anesthesia avoidance in pediatric patients: a multicenter trial; Int J Radiat Oncol Biol Phys; Vol 117(1), pp. 96-104. 2023 Jan 01.
    1. Mailhot VR
    2. Harker-Murray PD
    3. Forlenza CJ
    4. Cole P
    5. Kelly KM
    6. Milgrom SA
    7. Parikh RR
    8. Hodgson DC
    9. Castellino SM
    10. Kahn J
    11. Roberts KB
    12. Constine LS
    13. Hoppe BS
    Radiation therapy use in refractory and relapsed adolescent and young adult Hodgkin lymphoma: a report from the Children's Oncology Group; Int J Radiat Oncol Biol Phys; Vol 117(2), pp. 400-403. 2023 Jan 01.
    1. Bates JE
    2. Shrestha S
    3. Liu Q
    4. Smith SA
    5. Mulrooney DA
    6. Leisenring W
    7. Gibson T
    8. Robison LL
    9. Chow EJ
    10. Oeffinger KC
    11. Armstrong GT
    12. Constine LS
    13. Hoppe BS
    14. Lee C
    15. Yasui Y
    16. Howell RM
    Cardiac substructure radiation dose and risk of late cardiac disease in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study; J Clin Oncol; Vol 41(22), pp. 3826-3838. 2023 Jan 01.
    1. Chow EJ
    2. Aggarwal S
    3. Doody DR
    4. Aplenc R
    5. Armenian SH
    6. Baker KS
    7. Bhatia S
    8. Blythe N
    9. Colan SD
    10. Constine LS
    11. Freyer DR
    12. Kopp LM
    13. Laverdière C
    14. Leisenring WM
    15. Sasaki N
    16. Vrooman LM
    17. Asselin BL
    18. Schwartz CL
    19. Lipshultz SE
    Dexrazoxane and long-term heart function in survivors of childhood cancer; J Clin Oncol; Vol 41(12), pp. 2248-2257. 2023 Jan 01.
    1. Ehrhardt MJ
    2. Leerink JM
    3. Mulder RL
    4. Mavinkurve-Groothuis A
    5. Kok W
    6. Nohria A
    7. Nathan PC
    8. Merkx R
    9. de Baat E
    10. Asogwa OA
    11. Skinner R
    12. Wallace H
    13. Lieke FE
    14. de Ville DG
    15. M PM
    16. Bárdi E
    17. Pavasovic V
    18. van der PH
    19. Fresneau B
    20. Demoor-Goldschmidt C
    21. Hennewig U
    22. Steinberger J
    23. Plummer C
    24. Chen MH
    25. Teske AJ
    26. Haddy N
    27. van Dalen EC
    28. Constine LS
    29. Chow EJ
    30. Levitt G
    31. Hudson MM
    32. Kremer L
    33. Armenian SH
    Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group; Lancet Oncol; Vol 24(3), pp. 108-120. 2023 Jan 01.
    1. Cohen-Cutler S
    2. Kaplan C
    3. Olch A
    4. Wong K
    5. Malvar J
    6. Constine LS
    7. Freyer DR
    Impact of volumetric dosimetry on the projected cost of radiation-related late effects screening after childhood cancer: a real-world cohort analysis; Oncologist; Vol 28(9), pp. 784-792. 2023 Jan 01.
    1. Werk RS
    2. Koyama T
    3. Sun L
    4. Wolden S
    5. Kelly KM
    6. Constine LS
    7. Schwartz CL
    8. Friedman DL
    Post-traumatic stress symptoms in adolescent Hodgkin lymphoma survivors: a report from Children's Oncology Group AHOD0031; J Adolesc Young Adult Oncol; Vol 12(3), pp. 359-365. 2023 Jan 01.
    1. Chow EJ
    2. Aggarwal S
    3. Doody DR
    4. Aplenc R
    5. Armenian SH
    6. Baker KS
    7. Bhatia S
    8. Blythe N
    9. Colan SD
    10. Constine LS
    11. Freyer DR
    12. Kopp LM
    13. Laverdière C
    14. Leisenring WM
    15. Sasaki N
    16. Vrooman LM
    17. Asselin BL
    18. Schwartz CL
    19. Lipshultz SE
    Dexrazoxane and long-term heart function in survivors of childhood cancer; J Clin Oncol; Vol 41(12), pp. 2248-2257. 2023 Jan 01.
    1. Vassantachart A
    2. Olch AJ
    3. Jones M
    4. Marques C
    5. Ronckers C
    6. Constine LS
    7. Maduro JH
    8. de Boer C
    9. Wong K
    A comprehensive review of 30 years of pediatric clinical trial radiotherapy dose constraints; Pediatr Blood Cancer; Vol 70(5). 2023 Jan 01.
    1. Bouchard EG
    2. Prince MA
    3. McCarty C
    4. Vincent PC
    5. Patel H
    6. LaValley SA
    7. Collins RL
    8. Sahler OJZ
    9. Krenz T
    10. Kelly KM
    Understanding social network support, composition, and structure among cancer caregivers.; Psycho-oncology. 2023 Jan 01.
    1. Geier CB
    2. Ellison M
    3. Cruz R
    4. Pawar S
    5. Leiss-Piller A
    6. Zmajkovicova K
    7. McNulty SM
    8. Yilmaz M
    9. Evans MO
    10. Gordon S
    11. Ujhazi B
    12. Wiest I
    13. Abolhassani H
    14. Aghamohammadi A
    15. Barmettler S
    16. Bhar S
    17. Bondarenko A
    18. Bolyard AA
    19. Buchbinder D
    20. Cada M
    21. Cavieres M
    22. Connelly JA
    23. Dale DC
    24. Deordieva E
    25. Dorsey MJ
    26. Drysdale SB
    27. Ehl S
    28. Elfeky R
    29. Fioredda F
    30. Firkin F
    31. Förster-Waldl E
    32. Geng B
    33. Goda V
    34. Gonzalez-Granado L
    35. Grunebaum E
    36. Grzesk E
    37. Henrickson SE
    38. Hilfanova A
    39. Hiwatari M
    40. Imai C
    41. Ip W
    42. Jyonouchi S
    43. Kanegane H
    44. Kawahara Y
    45. Khojah AM
    46. Kim VH
    47. Kojić M
    48. Kołtan S
    49. Krivan G
    50. Langguth D
    51. Lau YL
    52. Leung D
    53. Miano M
    54. Mersyanova I
    55. Mousallem T
    56. Muskat M
    57. Naoum FA
    58. Noronha SA
    59. Ouederni M
    60. Ozono S
    61. Richmond GW
    62. Sakovich I
    63. Salzer U
    64. Schuetz C
    65. Seeborg FO
    66. Sharapova SO
    67. Sockel K
    68. Volokha A
    69. von Bonin M
    70. Warnatz K
    71. Wegehaupt O
    72. Weinberg GA
    73. Wong KJ
    74. Worth A
    75. Yu H
    76. Zharankova Y
    77. Zhao X
    78. Devlin L
    79. Badarau A
    80. Csomos K
    81. Keszei M
    82. Pereira J
    83. Taveras AG
    84. Beaussant-Cohen SL
    85. Ong MS
    86. Shcherbina A
    87. Walter JE
    Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients.; Journal of clinical immunology. 2022 Aug 10.
    1. Voll M
    2. Fairclough DL
    3. Morrato EH
    4. McNeal DM
    5. Embry L
    6. Pelletier W
    7. Noll RB
    8. Sahler OJZ
    Dissemination of an evidence-based behavioral intervention to alleviate distress in caregivers of children recently diagnosed with cancer: Bright IDEAS.; Pediatric blood & cancer; Vol 69(10), pp. e29904. 2022 Aug 04.
    1. Tarlock K
    2. Sulis ML
    3. Chewning JH
    4. Pollard JA
    5. Cooper T
    6. Gamis A
    7. Shenoy S
    8. Kutny M
    9. Horan J
    10. Meshinchi S
    11. Boelens JJ
    12. Bleakley M
    13. Carpenter PA
    14. Kolb EA
    Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular Therapy.; Transplantation and cellular therapy; Vol 28(9), pp. 530-545. 2022 Jun 16.
    1. Bouchard EG
    2. Collins RL
    3. Vincent PC
    4. Patel H
    5. Sahler O
    6. McCarty C
    7. Prince MA
    8. Kelly KM
    An initial investigation of using smartphone-enabled micro-temporal data collection to increase acceptability, feasibility, and validity of research on cancer caregiving; Pediatr Blood Cancer; Vol e29886, pp. 1-6. 2022 Jan 01.
    1. Atkins MH
    2. Scarfò R
    3. McGrath KE
    4. Yang D
    5. Palis J
    6. Ditadi A
    7. Keller GM
    Modeling human yolk sac hematopoiesis with pluripotent stem cells.; The Journal of experimental medicine; Vol 219(3). 2022 Mar 07.
    1. Noyes K
    2. Zapf AL
    3. Depner RN
    4. Flores T
    5. Huston A
    6. Rashid HH
    7. McNeal D
    8. Constine LS
    9. Fleming FJ
    10. Wilding GE
    11. Sahler O
    Problem-solving skills training in adult cancer survivors: Bright IDEAS-AC pilot study; Cancer Treatment and Research Communications; Vol 31, pp. 1-7. 2022 Jan 01.
    1. Nemkov T
    2. Kingsley PD
    3. Dzieciatkowska M
    4. Malik J
    5. McGrath K
    6. Hansen KC
    7. D'Alessandro A
    8. Palis J
    Circulating primitive murine erythroblasts undergo complex proteomic and metabolomic changes during terminal maturation.; Blood advances. 2022 Feb 09.
    1. Qayed M
    2. Watkins B
    3. Gillespie S
    4. Bratrude B
    5. Betz K
    6. Choi SW
    7. Davis J
    8. Duncan C
    9. Giller R
    10. Grimley M
    11. Harris AC
    12. Jacobsohn D
    13. Lalefar N
    14. Norkin M
    15. Farhadfar N
    16. Pulsipher MA
    17. Shenoy S
    18. Petrovic A
    19. Schultz KR
    20. Yanik GA
    21. Waller EK
    22. Langston A
    23. Kean LS
    24. Horan JT
    Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation.; Blood advances; Vol 6(3), pp. 746-749. 2022 Feb 08.
    1. Dvorak CC
    2. Haddad E
    3. Heimall J
    4. Dunn E
    5. Cowan MJ
    6. Pai SY
    7. Kapoor N
    8. Satter LF
    9. Buckley RH
    10. O'Reilly RJ
    11. Chandra S
    12. Bednarski JJ
    13. Williams O
    14. Rayes A
    15. Moore TB
    16. Ebens CL
    17. Davila Saldana BJ
    18. Petrovic A
    19. Chellapandian D
    20. Cuvelier GDE
    21. Vander Lugt MT
    22. Caywood EH
    23. Chandrakasan S
    24. Eissa H
    25. Goldman FD
    26. Shereck E
    27. Aquino VM
    28. Desantes KB
    29. Madden LM
    30. Miller HK
    31. Yu L
    32. Broglie L
    33. Gillio A
    34. Shah AJ
    35. Knutsen AP
    36. Andolina JP
    37. Joshi AY
    38. Szabolcs P
    39. Kapadia M
    40. Martinez CA
    41. Parrot RE
    42. Sullivan KE
    43. Prockop SE
    44. Abraham RS
    45. Thakar MS
    46. Leiding JW
    47. Kohn DB
    48. Pulsipher MA
    49. Griffith LM
    50. Notarangelo LD
    51. Puck JM
    The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions.; The Journal of allergy and clinical immunology. 2022 Jan 28.
    1. Parisi R
    2. Patel RR
    3. Rood G
    4. Bowden A
    5. Turco G
    6. Korones DN
    7. Andolina JR
    8. Comito M
    9. Barth M
    10. Weintraub L
    Multi-institution analysis of tumor mutational burden and outcomes in pediatric central nervous system tumor patients.; Pediatric blood & cancer. 2022 Jan 26.
    1. Stenger E
    2. Xiang Y
    3. Wetzel M
    4. Gillespie S
    5. Chellapandian D
    6. Shah R
    7. Arnold SD
    8. Bhatia M
    9. Chaudhury S
    10. Eckrich MJ
    11. Kanter J
    12. Kasow KA
    13. Krajewski J
    14. Nickel RS
    15. Ngwube AI
    16. Olson TS
    17. Rangarajan HG
    18. Wobma H
    19. Guilcher GMT
    20. Horan JT
    21. Krishnamurti L
    22. Shenoy S
    23. Abraham A
    Long-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research Alliance.; Transplantation and cellular therapy; Vol 29(1), pp. 47.e1-47.e10. 2022 Jan 20.
    1. Andolina JR
    2. Wang YC
    3. Ji L
    4. Freyer DR
    5. Levine JE
    6. Pulsipher MA
    7. Gamis AS
    8. Aplenc R
    9. Roth ME
    10. Harrison L
    11. Cairo MS
    Adolescent and young adult (AYA) versus pediatric patients with acute leukemia have a significantly increased risk of acute GVHD following unrelated donor (URD) stem cell transplantation (SCT): the Children's Oncology Group experience.; Bone marrow transplantation; Vol 57(3), pp. 445-452. 2022 Jan 06.
    1. Fries C
    2. Lee LW
    3. Devidas M
    4. Dai Y
    5. Rabin KR
    6. Gupta S
    7. Loh ML
    8. Kirsch IR
    9. Wood B
    10. Rau RE
    Prognostic impact of pre-treatment immunoglobulin clonal composition in pediatric Blymphoblastic leukemia.; Haematologica. 2022 Jan 03.
    1. Fries C
    2. Long AM
    3. Marston BA
    4. Andolina JR
    Migratory Arthralgia in a 3-year-old Girl.; Pediatrics in review; Vol 43(1), pp. 41-44. 2022 Jan 01.
    1. Chow EJ
    2. Aplenc R
    3. Vrooman LM
    4. Doody DR
    5. Huang YV
    6. Aggarwal S
    7. Armenian SH
    8. Baker KS
    9. Bhatia S
    10. Constine LS
    11. Freyer DR
    12. Kopp LM
    13. Leisenring WM
    14. Asselin BL
    15. Schwartz CL
    16. Lipshultz SE
    Late health outcomes after dexrazoxane treatment: a report from the Children's Oncology Group; Cancer; Vol 128(4), pp. 788-796. 2022 Jan 01.
    1. Lipshultz ER
    2. Chow EJ
    3. Doody DR
    4. Armenian SH
    5. Asselin BL
    6. Baker KS
    7. Bhatia S
    8. Constine LS
    9. Freyer DR
    10. Kopp LM
    11. Schwartz CL
    12. Lipshultz SE
    13. Vrooman LM
    Cardiometabolic risk in childhood cancer survivors: a report from the Children's Oncology Group; Cancer Epidemiol Biomarkers Prev; Vol 31(3), pp. 536-542. 2022 Jan 01.
    1. Hall MD
    2. Terezakis SA
    3. Lucas JT
    4. Gallop-Evans E
    5. Dieckmann K
    6. Constine LS
    7. Hodgson D
    8. Flerlage JE
    9. Metzger ML
    10. Hoppe BS
    Radiation Therapy Across Pediatric Hodgkin Lymphoma Research Group Protocols: A Report From the Staging, Evaluation, and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent, and Young Adult Hodgkin Lymphoma (CAYAHL) Group .; Int J Radiat Oncol Biol Phys; Vol 112(2), pp. 317-334. 2022 Jan 01.
    1. Devine KA
    2. Christen S
    3. Mulder RL
    4. Brown MC
    5. Ingerski LM
    6. Mader L
    7. Potter E
    8. Sleurs C
    9. Viola A
    10. Waern S
    11. Constine LS
    12. Hudson MM
    13. Kremer L
    14. Skinner R
    15. Michel G
    16. Marchak JG
    17. Schulte F
    18. on BO
    19. the IP
    20. late EG
    Recommendations for the surveillance of education and employment outcomes in survivors of childhood, adolescent and young adult cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group; Cancer; Vol 128(13), pp. 2405-2419. 2022 Jan 01.
    1. Noyes K
    2. Zapf AL
    3. Depner RM
    4. Flores T
    5. Huston A
    6. Rashid HH
    7. McNeal D
    8. Constine LS
    9. Fleming FJ
    10. Wilding GE
    11. Sahler O
    Problem-solving skills training in adult cancer survivors: Bright IDEAS-AC pilot study; Cancer Treat Res Commun; Vol 31. 2022 Jan 01.
    1. Marchak JG
    2. Christen S
    3. Mulder RL
    4. Baust K
    5. Blom J
    6. Brinkman TM
    7. Elens I
    8. Harju E
    9. Kadan-Lottick NS
    10. Khor J
    11. Lemiere J
    12. Recklitis CJ
    13. Wakefield CE
    14. Wiener L
    15. Constine LS
    16. Hudson MM
    17. Kremer L
    18. Skinner R
    19. Vetsch J
    20. Lee JL
    21. Michel G
    22. International GH
    23. Group PL
    24. effects G
    Recommendations for the surveillance of mental health problems in childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group; Lancet Oncol; Vol 23(4), pp. 184-196. 2022 Jan 01.
    1. Lo AC
    2. Major A
    3. Super L
    4. Appel B
    5. Shankar A
    6. Constine LS
    7. Marks LJ
    8. Kelly KM
    9. Metzger ML
    10. Buhtoiarov IN
    11. Mauz-Körholz C
    12. Costa A
    13. Binkley MS
    14. Flerlage J
    Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW); Leuk Lymphoma; Vol 63(8), pp. 1997-2000. 2022 Jan 01.
    1. Komisarof J
    2. Lipof J
    3. DiTursi J
    4. Chowdhry A
    5. Grace CH
    6. Burack WR
    7. Constine L
    8. Passero F
    An unusual case of multiple myeloma with light-chain cast nephropathy secondary to a very large plasmacytoma without bone marrow involvement; Case Rep Hematol; Vol 2022. 2022 Jan 01.
    1. van Iersel L
    2. Mulder RL
    3. Denzer C
    4. Cohen LE
    5. Spoudeas HA
    6. Meacham LR
    7. Sugden E
    8. Schouten-van MA
    9. Hoving EW
    10. Packer RJ
    11. Armstrong GT
    12. Mostoufi-Moab S
    13. Stades AM
    14. van Vuurden D
    15. Janssens GO
    16. Thomas-Teinturier C
    17. Murray RD
    18. Di Iorgi N
    19. Neggers S
    20. Thompson J
    21. Toogood AA
    22. Gleeson H
    23. Follin C
    24. Bardi E
    25. Torno L
    26. Patterson B
    27. Morsellino V
    28. Sommer G
    29. Clement SC
    30. Srivastava D
    31. Kiserud CE
    32. Fernandez A
    33. Scheinemann K
    34. Raman S
    35. Yuen K
    36. Wallace WH
    37. Constine LS
    38. et A
    Hypothalamic-pituitary and other endocrine surveillance among childhood cancer survivors; Endocr Rev; Vol 43(5), pp. 794-823. 2022 Jan 01.
    1. McNeal DM
    2. Sahler OJ
    3. Noll RB
    4. Fairclough DL
    5. Voll ME
    6. Bha TS
    7. Morrato EH
    Core functions and forms of Bright IDEAS: A multi-methods evaluation of the adoption of an evidence-based psychosocial training program through literative adaption; Frontiers in Health Services; Vol 96. 2022 Jan 01.
    1. Alabdaljabar MS
    2. Durani U
    3. Thompson CA
    4. Constine LS
    5. Hashmi SK
    The forgotten survivor: A comprehensive review on Non-Hodgkin lymphoma survivorship; Am J Hematol; Vol 97(12), pp. 1627-1637. 2022 Jan 01.
    1. Parekh A
    2. Keller FG
    3. McCarten KM
    4. Kessel S
    5. Cho S
    6. Pei Q
    7. Wu Y
    8. Castellino SM
    9. Constine LS
    10. Schwartz CL
    11. Hodgson D
    12. Kelly KM
    13. Hoppe BS
    Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis; Blood; Vol 140(10), pp. 1086-1093. 2022 Jan 01.
    1. Stephens DM
    2. Li H
    3. Constine LS
    4. Fitzgerald TJ
    5. Leonard JP
    6. Kahl BS
    7. Song JY
    8. LeBlanc ML
    9. Smith SM
    10. Persky DO
    11. Friedberg JW
    Extranodal presentation in limited-stage diffuse large Bcell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001; Haematologica; Vol 107(11), pp. 2732-2736. 2022 Jan 01.
    1. Dolgin MJ
    2. Devine KA
    3. Tzur-Bitan D
    4. Askins MA
    5. Fairclough DL
    6. Katz ER
    7. Noll RB
    8. Phipps S
    9. Sahler O
    Responsivity to Problem-Solving Skills Training in Mothers of Children with Cancer; Oxford University Press; Journal of Pediatric Psychology; Vol 46(4), pp. 413-421. 2021 Jan 01.
    1. Eastburg L
    2. Russler-Germain DA
    3. DiPersio JF
    4. Fountaine T
    5. Andolina JR
    6. Abboud R
    7. Huselton E
    Increased early mortality after fludarabine and melphalan conditioning with peripheral blood grafts in haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide.; Leukemia & lymphoma. 2021 Nov 18.
    1. Winter MA
    2. Greelee J
    3. Ghriwati NA
    4. Garr KN
    5. Sahler O
    Children's appraisals of threat in pediatric cancer; SSM - Mental Health 1. 2021 Jan 01.
    1. Zhang Y
    2. McGrath KE
    3. Ayoub E
    4. Kingsley PD
    5. Yu H
    6. Fegan K
    7. McGlynn KA
    8. Rudzinskas S
    9. Palis J
    10. Perkins AS
    Mds1CreERT2, an inducible Cre allele specific to adult-repopulating hematopoietic stem cells.; Cell reports; Vol 36(7). 2021 Aug 17.
    1. Jeffery NN
    2. Davidson C
    3. Peslak SA
    4. Kingsley PD
    5. Nakamura Y
    6. Palis J
    7. Bulger M
    Histone H2A.X phosphorylation and Caspase-Initiated Chromatin Condensation in late-stage erythropoiesis.; Epigenetics & chromatin; Vol 14(1). 2021 Jul 30.
    1. Saunders J
    2. Niswander LM
    3. McGrath KE
    4. Koniski A
    5. Catherman SC
    6. Ture SK
    7. Medhora M
    8. Kingsley PD
    9. Calvi LM
    10. Williams JP
    11. Morrell CN
    12. Palis J
    Long-acting PGE2 and Lisinopril Mitigate H-ARS.; Radiation research. 2021 Jun 21.
    1. Fries C
    2. Noronha SA
    3. Metlay L
    4. Zhang B
    Transplacental transfer of congenital B-cell acute lymphoblastic leukemia to the maternal vasculature.; Pediatric blood & cancer; Vol 68(9), pp. e29142. 2021 Jun 14.
    1. Farris N
    2. Sampson M
    Single-agent rituximab for treatment of multifocal and multiple relapsed pulmonary inflammatory myofibroblastic tumor in an adolescent patient.; Pediatric blood & cancer; Vol 68(9), pp. e29131. 2021 Jun 08.
    1. Schenone D
    2. Andolina JR
    3. Rademacher B
    4. Fountaine TJ
    5. Edwards E
    6. Nunez L
    7. Qiu M
    8. Sharma S
    9. Mullen CA
    Gene Expression and Survival of Acute Lymphoblastic Leukemia Cells After Allogeneic Transplant.; Anticancer research; Vol 41(6). 2021 Jun.
    1. Kaplan FS
    2. Teachey DT
    3. Andolina JR
    4. Siegel DM
    5. Mancilla EE
    6. Hsiao EC
    7. Al Mukaddam M
    8. Rocke DM
    9. Pignolo RJ
    Off-on-off-on use of imatinib in three children with fibrodysplasia ossificans progressiva.; Bone; Vol 150. 2021 May 19.
    1. Fries C
    2. Girvin AR
    3. Korones DN
    4. Weintraub L
    5. Fitzpatrick L
    6. Andolina JR
    Myeloablative Carboplatin and Thiotepa With Autologous Stem Cell Rescue for Nonmedulloblastoma High-risk CNS Tumors in Young Children.; Journal of pediatric hematology/oncology. 2021 May 18.
    1. Casella JF
    2. Barton BA
    3. Kanter J
    4. Black LV
    5. Majumdar S
    6. Inati A
    7. Wali Y
    8. Drachtman RA
    9. Abboud MR
    10. Kilinc Y
    11. Fuh BR
    12. Al-Khabori MK
    13. Takemoto CM
    14. Salman E
    15. Sarnaik SA
    16. Shah N
    17. Morris CR
    18. Keates-Baleeiro J
    19. Raj A
    20. Alvarez OA
    21. Hsu LL
    22. Thompson AA
    23. Sisler IY
    24. Pace BS
    25. Noronha SA
    26. Lasky JL
    27. de Julian EC
    28. Godder K
    29. Thornburg CD
    30. Kamberos NL
    31. Nuss R
    32. Marsh AM
    33. Owen WC
    34. Schaefer A
    35. Tebbi CK
    36. Chantrain CF
    37. Cohen DE
    38. Karakas Z
    39. Piccone CM
    40. George A
    41. Fixler JM
    42. Singleton TC
    43. Moulton T
    44. Quinn CT
    45. de Castro Lobo CL
    46. Almomen AM
    47. Goyal-Khemka M
    48. Maes P
    49. Emanuele M
    50. Gorney RT
    51. Padgett CS
    52. Parsley E
    53. Kronsberg SS
    54. Kato GJ
    55. Gladwin MT
    Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.; JAMA; Vol 325(15), pp. 1513-1523. 2021 Apr 20.
    1. Andolina JR
    2. Fries C
    3. Boulware R
    4. Vargas A
    5. Fraint E
    6. Barth M
    7. Abrusko S
    8. Comito M
    9. Monteleone P
    Successful Bone Marrow Transplantation With Intensive Post-transplant Intrathecal Chemotherapy for CNS Relapsed AML in 2 Infants.; Journal of pediatric hematology/oncology. 2021 Apr 09.
    1. Fries C
    2. Evans AG
    3. Cheon H
    4. Korones DN
    5. Loughran TP
    6. Andolina JR
    Allogeneic Bone Marrow Transplant as a Cure for Refractory T-Cell Large Granular Lymphocytic Leukemia in an Adolescent.; Journal of pediatric hematology/oncology; Vol 44(6), pp. e960-e963. 2021 Jan 29.
    1. Smith SM
    2. Zhang S
    3. Sundaram V
    4. Roth M
    5. Andolina JR
    6. Schapira L
    7. Sakamoto KM
    8. Kolb EA
    9. Hijiya N
    10. Chaudhury S
    Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML.; Pediatric hematology and oncology; Vol 39(5), pp. 453-467. 2021 Jan 17.
    1. Watkins B
    2. Qayed M
    3. McCracken C
    4. Bratrude B
    5. Betz K
    6. Suessmuth Y
    7. Yu A
    8. Sinclair S
    9. Furlan S
    10. Bosinger S
    11. Tkachev V
    12. Rhodes J
    13. Tumlin AG
    14. Narayan A
    15. Cribbin K
    16. Gillespie S
    17. Gooley TA
    18. Pasquini MC
    19. Hebert K
    20. Kapoor U
    21. Rogatko A
    22. Tighiouart M
    23. Kim S
    24. Bresee C
    25. Choi SW
    26. Davis J
    27. Duncan C
    28. Giller R
    29. Grimley M
    30. Harris AC
    31. Jacobsohn D
    32. Lalefar N
    33. Norkin M
    34. Farhadfar N
    35. Pulsipher MA
    36. Shenoy S
    37. Petrovic A
    38. Schultz KR
    39. Yanik GA
    40. Waller EK
    41. Levine JE
    42. Ferrara JL
    43. Blazar BR
    44. Langston A
    45. Horan JT
    46. Kean LS
    Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology; Vol 39(17), pp. 1865-1877. 2021 Jan 15.
    1. Avutu V
    2. Monga V
    3. Mittal N
    4. Saha A
    5. Andolina JR
    6. Bell DE
    7. Fair DB
    8. Flerlage JE
    9. Frediani JN
    10. Heath JL
    11. Kahn JM
    12. Reichek JL
    13. Super L
    14. Terao MA
    15. Freyer DR
    16. Roth ME
    Use of Communication Technology to Improve Clinical Trial Participation in Adolescents and Young Adults With Cancer: Consensus Statement From the Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network.; JCO oncology practice; Vol 18(3), pp. 224-231. 2021 Jan 14.
    1. Tkachev V
    2. Kaminski J
    3. Potter EL
    4. Furlan SN
    5. Yu A
    6. Hunt DJ
    7. McGuckin C
    8. Zheng H
    9. Colonna L
    10. Gerdemann U
    11. Carlson J
    12. Hoffman M
    13. Olvera J
    14. English C
    15. Baldessari A
    16. Panoskaltsis-Mortari A
    17. Watkins B
    18. Qayed M
    19. Suessmuth Y
    20. Betz K
    21. Bratrude B
    22. Langston A
    23. Horan JT
    24. Ordovas-Montanes J
    25. Shalek AK
    26. Blazar BR
    27. Roederer M
    28. Kean LS
    Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8+ T cells drive gastrointestinal acute graft-versus-host disease.; Science translational medicine; Vol 13(576). 2021 Jan 13.
    1. Meier ER
    2. Abraham AA
    3. Ngwube A
    4. Janson IA
    5. Guilcher GMT
    6. Horan J
    7. Kasow KA
    Hematopoietic stem cell transplant referral patterns for children with sickle cell disease vary among pediatric hematologist/oncologists' practice focus: A Sickle Cell Transplant Advocacy and Research Alliance (STAR) study.; Pediatric blood & cancer; Vol 68(3), pp. e28861. 2021 Jan 06.
    1. McNeal DM
    2. Sahler OJ
    3. Noll RB
    4. Fairclough DL
    5. Voll ME
    6. Bha TS
    7. Morrato EH
    Evaluating the national implementation of Bright IDEAS in clinical settings: Applying the r-Aim/framework to characterize the clinical perspective.; Research Square. 2021 Jan 01.
    1. van Atteveld JE
    2. Mulder RL
    3. van den HM
    4. Hudson MM
    5. Kremer L
    6. Skinner R
    7. Wallace WH
    8. Constine LS
    9. Higham CE
    10. Kaste SC
    11. Niinimäki R
    12. Mostoufi-Moab S
    13. Alos N
    14. Fintini D
    15. Templeton KJ
    16. Ward LM
    17. Frey E
    18. Franceschi R
    19. Pavasovic V
    20. Karol SE
    21. Amin NL
    22. Vrooman LM
    23. Harila-Saari A
    24. Demoor-Goldschmidt C
    25. Murray RD
    26. Bardi E
    27. Lequin MH
    28. Faienza MF
    29. Zaikova O
    30. Berger C
    31. Mora S
    32. Ness KK
    33. Neggers S
    34. Pluijm S
    35. Simmons JH
    36. Di Iorgi N
    Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group; Lancet Diabetes Endocrinol; Vol 9(9), pp. 622-637. 2021 Jan 01.
    1. Kwiatkowski V
    2. Franco AI
    3. Cordisco MR
    4. Mullen CA
    A case of a rapidly-changing skin lesion in an 11-year-old male; Pediatrics In Review. 2021 Jan 01.
    1. Lo AC
    2. Dieckmann K
    3. Pelz T
    4. Gallop-Evans E
    5. Engenhart-Cabillic R
    6. Vordermark D
    7. Kelly KM
    8. Schwartz CL
    9. Constine LS
    10. Roberts K
    11. Hodgson D
    Pediatric classical Hodgkin lymphoma; Pediatr Blood Cancer; Vol 68(Suppl 2). 2021 Jan 01.
    1. Palmer JD
    2. Tsang DS
    3. Tinkle CL
    4. Olch AJ
    5. Kremer L
    6. Ronckers CM
    7. Gibbs IC
    8. Constine LS
    Late effects of radiation therapy in pediatric patients and survivorship; Pediatr Blood Cancer; Vol 68(Suppl 2). 2021 Jan 01.
    1. van Dalen EC
    2. Mulder RL
    3. Suh E
    4. Ehrhardt MJ
    5. Aune GJ
    6. Bardi E
    7. Benson BJ
    8. Bergler-Klein J
    9. Chen MH
    10. Frey E
    11. Hennewig U
    12. Lockwood L
    13. Martinsson U
    14. Muraca M
    15. van der PH
    16. Plummer C
    17. Scheinemann K
    18. Schindera C
    19. Tonorezos ES
    20. Wallace WH
    21. Constine LS
    22. Skinner R
    23. Hudson MM
    24. Kremer L
    25. Levitt G
    26. Mulrooney DA
    Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group; Eur J Cancer; Vol 156, pp. 127-137. 2021 Jan 01.
    1. Vogel J
    2. Hui S
    3. Hua CH
    4. Dusenbery K
    5. Rassiah P
    6. Kalapurakal J
    7. Constine L
    8. Esiashvili N
    Pulmonary Toxicity After Total Body Irradiation - Critical Review of the Literature and Recommendations for Toxicity Reporting; Front Oncol; Vol 11. 2021 Jan 01.
    1. Shrestha S
    2. Bates JE
    3. Liu Q
    4. Smith SA
    5. Oeffinger KC
    6. Chow EJ
    7. Gupta AC
    8. Owens CA
    9. Constine LS
    10. Hoppe BS
    11. Leisenring WM
    12. Qiao Y
    13. Weathers RE
    14. Court LE
    15. Pinnix CC
    16. Kry SF
    17. Mulrooney DA
    18. Armstrong GT
    19. Yasui Y
    20. Howell RM
    Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study; Radiother Oncol; Vol 163, pp. 199-208. 2021 Jan 01.
    1. Bardi E
    2. Mulder RL
    3. van Dalen EC
    4. Bhatt NS
    5. Ruble KA
    6. Burgis J
    7. Castellino SM
    8. Constine LS
    9. den HC
    10. Green DM
    11. Koot B
    12. Levitt G
    13. Szonyi L
    14. Wallace WH
    15. Skinner R
    16. Hudson MM
    17. Kremer L
    18. Effinger KE
    19. Bresters D
    Late hepatic toxicity surveillance for survivors of childhood, adolescent and young adult cancer: recommendations from the international late effects of childhood cancer guideline harmonization group.; Cancer Treat Rev; Vol 100. 2021 Jan 01.
    1. Delgadillo LF
    2. Huang YS
    3. Leon S
    4. Palis J
    5. Waugh RE
    Development of Mechanical Stability in Late-Stage Embryonic Erythroid Cells: Insights From Fluorescence Imaged Micro-Deformation Studies.; Frontiers in physiology; Vol 12. 2021.
    1. Webster M
    2. Tanny S
    3. Joyce N
    4. Herman A
    5. Chen Y
    6. Milano M
    7. Usuki K
    8. Constine L
    9. Singh D
    10. Yeo I
    New dosimetric guidelines for linear Boltzmann transport equations through comparative evaluation of stereotactic body radiation therapy for lung treatment planning; J Appl Clin Med Phys; Vol 22(12), pp. 115-124. 2021 Jan 01.
    1. Bates JE
    2. Chen MH
    3. Constine LS
    Radiation-Associated Coronary Disease in Young Cancer Survivors: The Beat Goes On; We Must Preserve It; JACC CardioOncol; Vol 3(3), pp. 393-396. 2021 Jan 01.
    1. Kumar A
    2. Casulo C
    3. Advani RH
    4. Budde E
    5. Barr PM
    6. Batlevi CL
    7. Caron P
    8. Constine LS
    9. Dandapani SV
    10. Drill E
    11. Drullinsky P
    12. Friedberg JW
    13. Grieve C
    14. Hamilton A
    15. Hamlin PA
    16. Hoppe RT
    17. Horwitz SM
    18. Joseph A
    19. Khan N
    20. Laraque L
    21. Matasar MJ
    22. Moskowitz AJ
    23. Noy A
    24. Palomba M
    25. Schroder H
    26. Straus DJ
    27. Vemuri S
    28. Yang J
    29. Younes A
    30. Zelenetz AD
    31. Yahalom J
    32. Moskowitz CH
    Brentuximab Vedotin combined with chemotherapy in patients with newly diagnosed early-stage, unfavorable-risk Hodgkin lymphoma; J Clin Oncol; Vol 39(20), pp. 2257-2265. 2021 Jan 01.
    1. Mulder RL
    2. Font-Gonzalez A
    3. Hudson MM
    4. van Santen HM
    5. Loeffen E
    6. Burns KC
    7. Quinn GP
    8. van Dulmen-den BE
    9. Byrne J
    10. Haupt R
    11. Wallace WH
    12. van den HM
    13. Anazodo A
    14. Anderson RA
    15. Barnbrock A
    16. Beck JD
    17. Bos A
    18. Demeestere I
    19. Denzer C
    20. Di Iorgi N
    21. Hoefgen HR
    22. Kebudi R
    23. Lambalk C
    24. Langer T
    25. Meacham LR
    26. Rodriguez-Wallberg K
    27. Stern C
    28. Stutz-Grunder E
    29. van Dorp W
    30. Veening M
    31. Veldkamp S
    32. van der ME
    33. Constine LS
    34. Kenney LB
    35. van de WM
    36. Kremer L
    37. Levine J
    38. Tissing W
    39. PanCareLIFE C
    Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group.; Lancet Oncol; Vol 22(2), pp. 45-56. 2021 Jan 01.
    1. Mulder RL
    2. Font-Gonzalez A
    3. Green DM
    4. Loeffen E
    5. Hudson MM
    6. Loonen J
    7. Yu R
    8. Ginsberg JP
    9. Mitchell RT
    10. Byrne J
    11. Skinner R
    12. Anazodo A
    13. Constine LS
    14. de Vries A
    15. Jahnukainen K
    16. Lorenzo A
    17. Meissner A
    18. Nahata L
    19. Dinkelman-Smit M
    20. Tournaye H
    21. Haupt R
    22. van den HM
    23. van Santen HM
    24. van Pelt A
    25. Dirksen U
    26. den HJ
    27. van Dulmen-den BE
    28. Wallace WH
    29. Levine J
    30. Tissing W
    31. Kremer L
    32. Kenney LB
    33. van de WM
    34. PanCareLIFE C
    Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group; Lancet Oncol; Vol 22(2), pp. 57-67. 2021 Jan 01.
    1. Dorsey MJ
    2. Wright NAM
    3. Chaimowitz NS
    4. Dávila Saldaña BJ
    5. Miller H
    6. Keller MD
    7. Thakar MS
    8. Shah AJ
    9. Abu-Arja R
    10. Andolina J
    11. Aquino V
    12. Barnum JL
    13. Bednarski JJ
    14. Bhatia M
    15. Bonilla FA
    16. Butte MJ
    17. Bunin NJ
    18. Chandra S
    19. Chaudhury S
    20. Chen K
    21. Chong H
    22. Cuvelier GDE
    23. Dalal J
    24. DeFelice ML
    25. DeSantes KB
    26. Forbes LR
    27. Gillio A
    28. Goldman F
    29. Joshi AY
    30. Kapoor N
    31. Knutsen AP
    32. Kobrynski L
    33. Lieberman JA
    34. Leiding JW
    35. Oshrine B
    36. Patel KP
    37. Prockop S
    38. Quigg TC
    39. Quinones R
    40. Schultz KR
    41. Seroogy C
    42. Shyr D
    43. Siegel S
    44. Smith AR
    45. Torgerson TR
    46. Vander Lugt MT
    47. Yu LC
    48. Cowan MJ
    49. Buckley RH
    50. Dvorak CC
    51. Griffith LM
    52. Haddad E
    53. Kohn DB
    54. Logan B
    55. Notarangelo LD
    56. Pai SY
    57. Puck J
    58. Pulsipher MA
    59. Heimall J
    Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers.; Journal of clinical immunology; Vol 41(1). 2021 Jan.
    1. Hoppe BS
    2. Advani R
    3. Milgrom SA
    4. Bakst RL
    5. Ballas LK
    6. Dabaja BS
    7. Flowers CR
    8. Ha CS
    9. Mansur DB
    10. Metzger ML
    11. Pinnix CC
    12. Plastaras JP
    13. Roberts KB
    14. Smith SM
    15. Terezakis SA
    16. Kirwan JM
    17. Constine LS
    Primary Mediastinal B cell Lymphoma in the Positron-Emission Tomography Era: Executive Summary of the American Radium Society Appropriate Use Criteria; Int J Radiat Oncol Biol Phys; Vol 111(1), pp. 36-44. 2021 Jan 01.
    1. Bowers DC
    2. Verbruggen LC
    3. Kremer L
    4. Hudson MM
    5. Skinner R
    6. Constine LS
    7. Sabin ND
    8. Bhangoo R
    9. Haupt R
    10. Hawkins MM
    11. Jenkinson H
    12. Khan RB
    13. Klimo JP
    14. Pretorius P
    15. Ng A
    16. Reulen RC
    17. Ronckers CM
    18. Sadighi Z
    19. Scheinemann K
    20. Schouten-van MN
    21. Sugden E
    22. Teepen JC
    23. Ullrich NJ
    24. Walter A
    25. Wallace WH
    26. Oeffinger KC
    27. Armstrong GT
    28. van der PH
    29. Mulder RL
    Surveillance for subsequent neoplasms of the central nervous system for childhood, adolescent, and young adult cancer survivors: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group; Lancet Oncol; Vol 22(5), pp. 196-206. 2021 Jan 01.
    1. Oeffinger KC
    2. Stratton KL
    3. Hudson MM
    4. Leisenring WM
    5. Henderson TO
    6. Howell RM
    7. Wolden SL
    8. Constine LS
    9. Diller LR
    10. Sklar CA
    11. Nathan PC
    12. Castellino SM
    13. Barnea D
    14. Smith SA
    15. Hutchinson RJ
    16. Armstrong GT
    17. Robison LL
    Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor Study; J Clin Oncol; Vol 39(20), pp. 2266-2275. 2021 Jan 01.
    1. Cohen-Cutler S
    2. Olch A
    3. Wong K
    4. Malvar J
    5. Sposto R
    6. Kobierski P
    7. Sura A
    8. Constine LS
    9. Freyer DR
    Surveillance for radiation-related late effects in childhood cancer survivors: the impact of using volumetric dosimetry; Cancer Med; Vol 10, pp. 905-913. 2021 Jan 01.
    1. Ballas LK
    2. Metzger ML
    3. Milgrom SA
    4. Advani R
    5. Bakst RL
    6. Dabaja BS
    7. Flowers CR
    8. Ha CS
    9. Hoppe BS
    10. Mansur DB
    11. Pinnix CC
    12. Plastaras JP
    13. Roberts KB
    14. Smith SN
    15. Terezakis SA
    16. Constine LS
    Nodular lymphocyte predominant Hodgkin lymphoma: executive summary of the American Radium Society appropriate use criteria; Leuk Lymphoma; Vol 62(5), pp. 1057-1065. 2021 Jan 01.
    1. Giulino-Roth L
    2. Pei Q
    3. Buxton A
    4. Bush R
    5. Wu Y
    6. Wolden SL
    7. Constine LS
    8. Kelly KM
    9. Schwartz CL
    10. Friedman DL
    Subsequent malignant neoplasms among children with Hodgkin lymphoma: A report from the Children's Oncology Group; Blood; Vol 137(11), pp. 1449-1456. 2021 Jan 01.
    1. van der KA
    2. Mulder RL
    3. Hudson MM
    4. Kremer L
    5. Skinner R
    6. Constine LS
    7. van Dorp W
    8. van Dulmen-den BE
    9. Winther JF
    10. Wallace WH
    11. Waugh J
    12. Woodruff TK
    13. Anderson RA
    14. Armenian SH
    15. Bloemenkamp K
    16. Critchley H
    17. Demoor-Goldschmidt C
    18. Ehrhardt MJ
    19. Green DM
    20. Grobman WA
    21. Iwahata Y
    22. Krishna I
    23. Laven J
    24. Levitt G
    25. Meacham LR
    26. Miller ES
    27. Mulders A
    28. Polanco A
    29. Ronckers CM
    30. Samuel A
    31. Walwyn T
    32. van den HM
    33. Levine JM
    Counseling and surveillance of obstetric risks for female childhood, adolescent, and young adult cancer survivors: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group; Am J Obstet Gynecol; Vol 224(1), pp. 3-15. 2021 Jan 01.
    1. Palis J
    2. Yoder MC
    Endothelial Cells Transition to Blood Cells but Probably Not Back Again.; Circulation research; Vol 127(10). 2020 Oct 23.
    1. Pariser DN
    2. Hilt ZT
    3. Ture SK
    4. Blick-Nitko SK
    5. Looney MR
    6. Cleary SJ
    7. Roman-Pagan E
    8. Saunders Ii J
    9. Georas SN
    10. Veazey JM
    11. Madere F
    12. Tesoro Santos L
    13. Arne AM
    14. Huynh NP
    15. Livada AC
    16. Guerrero-Martin SM
    17. Lyons CE
    18. Metcalf Pate KA
    19. McGrath KE
    20. Palis J
    21. Morrell C
    Lung megakaryocytes are immune modulatory cells.; The Journal of clinical investigation. 2020 Oct 20.
    1. Fox S
    2. Myers JA
    3. Davidson C
    4. Getman M
    5. Kingsley PD
    6. Frankiewicz N
    7. Bulger M
    Hyperacetylated chromatin domains mark cell type-specific genes and suggest distinct modes of enhancer function.; Nature communications; Vol 11(1). 2020 Sep 11.
    1. Korones DN
    Am I Racist?; The New England journal of medicine; Vol 383(12), pp. e80. 2020 Sep 01.
    1. Phipps S
    2. Fairclough DL
    3. Noll RB
    4. Devine KA
    5. Dolgin MJ
    6. Schepers SA
    7. Askins MA
    8. Schneider NM
    9. Ingman K
    10. Voll M
    11. Katz ER
    12. McLaughlin J
    13. Sahler OJZ
    In-person vs. web-based administration of a problem-solving skills intervention for parents of children with cancer: Report of a randomized noninferiority trial.; EClinicalMedicine; Vol 24. 2020 Jul.
    1. Devine KA
    2. Viola A
    3. Levonyan-Radloff K
    4. Mackowski N
    5. Bozzini B
    6. Chandler A
    7. Xu B
    8. Ohman-Strickland P
    9. Mayans S
    10. Farrar-Anton A
    11. Sahler OJZ
    12. Masterson M
    13. Manne S
    14. Arent S
    Feasibility of FitSurvivor: A technology-enhanced group-based fitness intervention for adolescent and young adult survivors of childhood cancer.; Pediatric blood & cancer. 2020 Jun 26.
    1. Phipps S
    2. Fairclough DL
    3. Noll RB
    4. Devine KA
    5. Dolgin MJ
    6. Schepers SA
    7. Askins MA
    8. Schneider N
    9. lngman K
    10. Voll M
    11. Katz ER
    12. Sahler O
    In-Person vs. Online Administration of a Problem-Solving Skills Intervention for Parents of Children with Cancer: Report of a Randomized Noninferiority Trial; EClinical Medicine (Published by The Lancet); Vol 24(100428). 2020 Jan 01.
    1. Andolina JR
    2. Walia R
    3. Oliva J
    4. Baran A
    5. Liesveld J
    6. Becker MW
    7. Busacco A
    8. Coppage M
    Non-donor specific anti-human leukocyte antigen (HLA) antibodies are not associated with poor outcome in hematopoietic stem cell transplant recipients.; Hum Immunol; Vol S0198-8859(20), pp. 30318-9. 2020 Jan 01.
    1. Dege C
    2. Fegan KH
    3. Creamer JP
    4. Berrien-Elliott MM
    5. Luff SA
    6. Kim D
    7. Wagner JA
    8. Kingsley PD
    9. McGrath KE
    10. Fehniger TA
    11. Palis J
    12. Sturgeon CM
    Potently Cytotoxic Natural Killer Cells Initially Emerge from Erythro-Myeloid Progenitors during Mammalian Development.; Developmental cell; Vol 53(2). 2020 Apr 20.
    1. Fries C
    2. Adlowitz DG
    3. Spence JM
    4. Spence JP
    5. Rock PJ
    6. Burack WR
    Acute lymphoblastic leukemia clonal distribution between bone marrow and peripheral blood.; Pediatric blood & cancer. 2020 Apr 11.
    1. Farris N
    2. Raina R
    3. Tibrewal A
    4. Brown M
    5. Colvis M
    6. Schwaderer A
    7. Kusumi K
    Acute Kidney Injury Associated With Urinary Stone Disease in Children and Young Adults Presenting to a Pediatric Emergency Department.; Frontiers in pediatrics; Vol 8, pp. 591520. 2020 Jan 30.
    1. Buhlinger KM
    2. Borlagdan J
    3. Agegnehu B
    4. Fentie AM
    5. Bernstein AT
    6. Urick BY
    7. Roberts M
    8. Weitzman S
    9. Bekele W
    10. Korones D
    11. Alexander TB
    12. Broas J
    13. Shad A
    14. Dinkiye AM
    15. Clark SM
    16. Adam H
    17. Hailu D
    18. Muluneh B
    Results of a pre-implementation analysis of Ethiopia's National Pediatric Cancer Registry.; Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners; Vol 27(8), pp. 1940-1947. 2020 Jan 20.
    1. Hailu D
    2. Fufu Hordofa D
    3. Adam Endalew H
    4. Karimi Mutua D
    5. Bekele W
    6. Bonilla M
    7. Çeliker MY
    8. Challinor J
    9. Dotan A
    10. Habashy C
    11. Kumar PN
    12. Rodriguez-Galindo C
    13. Wali RM
    14. Weitzman S
    15. Broas J
    16. Korones DN
    17. Alexander TB
    18. Shad AT
    Training pediatric hematologist/oncologists for capacity building in Ethiopia.; Pediatric blood & cancer; Vol 67(12), pp. e28760. 2020 Jan 13.
    1. Cao J
    2. O'Day DR
    3. Pliner HA
    4. Kingsley PD
    5. Deng M
    6. Daza RM
    7. Zager MA
    8. Aldinger KA
    9. Blecher-Gonen R
    10. Zhang F
    11. Spielmann M
    12. Palis J
    13. Doherty D
    14. Steemers FJ
    15. Glass IA
    16. Trapnell C
    17. Shendure J
    A human cell atlas of fetal gene expression.; Science (New York, N.Y.); Vol 370(6518). 2020 Jan 13.
    1. Mulder RL
    2. Hudson MM
    3. Bhatia S
    4. Landier W
    5. Levitt G
    6. Constine LS
    7. Wallace WH
    8. van Leeuwen FE
    9. Ronckers CM
    10. Henderson TO
    11. Moskowitz CS
    12. Friedman DN
    13. Ng AK
    14. Jenkinson HC
    15. Demoor-Goldschmidt C
    16. Skinner R
    17. Kremer L
    18. Oeffinger KC
    Updated breast cancer surveillance recommendations for female survivors of childhood, adolescent, and young adult cancer from the International Guideline Harmonization Group; J Clin Oncol; Vol 38, pp. 4194-4207. 2020 Jan 01.
    1. Shrestha S
    2. Gupta AC
    3. Bates JE
    4. Lee C
    5. Owens CA
    6. Hoppe BS
    7. Constine LS
    8. Smith SA
    9. Qiao Y
    10. Weathers RE
    11. Yasui Y
    12. Court LE
    13. Paulino AC
    14. Pinnix CC
    15. Kry SF
    16. Followill DS
    17. Armstrong GT
    18. Howell RM
    Development and validation of an age-scalable cardiac model with substructures for dosimetry in late-effects studies of childhood cancer survivors; Radiother Oncol; Vol 153, pp. 163-171. 2020 Jan 01.
    1. Andolina JR
    StALKing Histiocytosis: ALK-positive histiocytosis identified through peripheral blood smear (in press); Acta Haematol. 2020 Jan 01.
    1. Chow EJ
    2. Ness KK
    3. Armstrong GT
    4. Bhakta N
    5. Yeh JM
    6. Bhatia S
    7. Landier W
    8. Constine LS
    9. Hudson MM
    10. Nathan PC
    Current and coming challenges in the management of the survivorship population; Semin Oncol; Vol 47(1), pp. 23-39. 2020 Jan 01.
    1. Chan AY
    2. Leiding JW
    3. Liu X
    4. Logan BR
    5. Burroughs LM
    6. Allenspach EJ
    7. Skoda-Smith S
    8. Uzel G
    9. Notarangelo LD
    10. Slatter M
    11. Gennery AR
    12. Smith AR
    13. Pai SY
    14. Jordan MB
    15. Marsh RA
    16. Cowan MJ
    17. Dvorak CC
    18. Craddock JA
    19. Prockop SE
    20. Chandrakasan S
    21. Kapoor N
    22. Buckley RH
    23. Parikh S
    24. Chellapandian D
    25. Oshrine BR
    26. Bednarski JJ
    27. Cooper MA
    28. Shenoy S
    29. Davila Saldana BJ
    30. Forbes LR
    31. Martinez C
    32. Haddad E
    33. Shyr DC
    34. Chen K
    35. Sullivan KE
    36. Heimall J
    37. Wright N
    38. Bhatia M
    39. Cuvelier GDE
    40. Goldman FD
    41. Meyts I
    42. Miller HK
    43. Seidel MG
    44. Vander Lugt MT
    45. Bacchetta R
    46. Weinacht KG
    47. Andolina JR
    48. Caywood E
    49. Chong H
    50. de la Morena MT
    51. Aquino VM
    52. Shereck E
    53. Walter JE
    54. Dorsey MJ
    55. Seroogy CM
    56. Griffith LM
    57. Kohn DB
    58. Puck JM
    59. Pulsipher MA
    60. Torgerson TR
    Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey.; Frontiers in immunology; Vol 11. 2020.
    1. Ehrhardt MJ
    2. Ward ZJ
    3. Liu Q
    4. Chaudhry A
    5. Nohria A
    6. Border W
    7. Fulbright JM
    8. Mulrooney DA
    9. Oeffinger KC
    10. Nathan PC
    11. Leisenring WM
    12. Constine LS
    13. Gibson TM
    14. Chow EJ
    15. Howell RM
    16. Robison LL
    17. Armstrong GT
    18. Hudson MM
    19. Diller L
    20. Yasui Y
    21. Armenian SH
    22. Yeh JM
    Cost-Effectiveness of the International Late Effects of Childhood Cancer Guideline Harmonization Group Screening Guidelines to Prevent Heart Failure in Survivors of Childhood Cancer; J Clin Oncol; Vol 38(33), pp. 3851-3862. 2020 Jan 01.
    1. Christen S
    2. Roser K
    3. Mulder RL
    4. Ilic A
    5. Lie HC
    6. Loonen JJ
    7. Mellblom AV
    8. Kremer L
    9. Hudson MM
    10. Constine LS
    11. Skinner R
    12. Scheinemann K
    13. Gilleland MJ
    14. Michel G
    15. IGHG PL
    16. effects G
    Recommendations for the surveillance of cancer-related fatigue in childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.; J Cancer Surviv; Vol 14, pp. 923-938. 2020 Jan 01.
    1. Hua CH
    2. Vern-Gross TZ
    3. Hess CB
    4. Olch AJ
    5. Alaei P
    6. Sathiaseelan V
    7. Deng J
    8. Ulin K
    9. Laurie F
    10. Gopalakrishnan M
    11. Esiashvili N
    12. Wolden SL
    13. Krasin MJ
    14. Merchant TE
    15. Donaldson SS
    16. FitzGerald TJ
    17. Constine LS
    18. Hodgson DC
    19. Haas-Kogan DA
    20. Mahajan A
    21. Laack NN
    22. Marcus KJ
    23. Taylor PA
    24. Ahern VA
    25. Followill DS
    26. Buchsbaum JC
    27. Breneman JC
    28. Kalapurakal JA
    Practice patterns and recommendations for pediatric image-guided radiotherapy: A Children's Oncology Group report; Pediatr Blood Cancer; Vol 67(10). 2020 Jan 01.
    1. Palmer JD
    2. Hall MD
    3. Mahajan A
    4. Paulino AC
    5. Wolden S
    6. Constine LS
    Radiotherapy and late effects; Pediatr Clin N Am; Vol 67(6), pp. 1051-1067. 2020 Jan 01.
    1. Wirth A
    2. Mikhaeel NG
    3. Aleman B
    4. Pinnix CC
    5. Constine LS
    6. Ricardi U
    7. Illidge TM
    8. Eich HT
    9. Hoppe BS
    10. Dabaja B
    11. Ng AK
    12. Kirova Y
    13. Berthelsen AK
    14. Dieckmann K
    15. Yahalom J
    16. Specht L
    Involved site radiation therapy in adult lymphomas: an overview of International Lymphoma Radiation Oncology Group Guidelines; Int J Radiat Oncol Biol Phys; Vol 107(5), pp. 909-933. 2020 Jan 01.
    1. Binkley M
    2. Rauf MS
    3. Milgrom S
    4. Pinnix C
    5. Tsang R
    6. Dickinson M
    7. Ng A
    8. Roberts K
    9. Gao S
    10. Balogh A
    11. Ricardi U
    12. Levis M
    13. Casulo C
    14. Stolten M
    15. Specht L
    16. Plastaras J
    17. Wright C
    18. Kelsey C
    19. Brady J
    20. Mikhaeel NG
    21. Hoppe B
    22. Terezakis S
    23. Picardi M
    24. Pepa RD
    25. Kirova Y
    26. Akhtar S
    27. Maghfoor I
    28. Koenig J
    29. Jackson C
    30. Song E
    31. Segal S
    32. Advani R
    33. Natkunam Y
    34. Constine LS
    35. Eich H
    36. Wirth A
    37. Hoppe R
    Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional experience of adult patients by ILROG; Blood; Vol 135(26), pp. 2365-2374. 2020 Jan 01.
    1. Bates JE
    2. Parikh RR
    3. Mendenhall NP
    4. Morris C
    5. Hoppe RT
    6. Constine LS
    7. Hoppe BS
    Long-term outcomes in ten-year survivors of early stage Hodgkin lymphoma; Int J Radiat Oncol Biol Phys; Vol 107(3), pp. 522-529. 2020 Jan 01.
    1. Budnik J
    2. Suri J
    3. Constine LS
    A (Sub)Mental Challenge; Int J Radiat Oncol Biol Phys; Vol 107(1), pp. 18-19. 2020 Jan 01.
    1. Budnik J
    2. Doucette C
    3. Milano MT
    4. Constine LS
    Survival of patients with second primary Hodgkin lymphoma; Clin Lymphoma Myeloma Leuk; Vol 20(5). 2020 Jan 01.
    1. Devine KA
    2. Viola A
    3. Levonyan-Radloff K
    4. Mackowski N
    5. Bozzini B
    6. Chandler A
    7. Xu B
    8. Ohman-Strickland P
    9. Mayans S
    10. Farrar-Anton A
    11. Sahler O
    Feasibility of FitSurvivor: A technology-enhanced group-based fitness intervention for adolescent and young adult survivors of childhood cancer; Pediatric Blood & Cancer; Vol 67. 2020 Jan 01.
    1. Mulrooney DA
    2. Hyun G
    3. Ness KK
    4. Ehrhardt MJ
    5. Yasui Y
    6. Duprez D
    7. Howell RM
    8. Leisenring WM
    9. Constine LS
    10. Tonorezos E
    11. Gibson TM
    12. Robison LL
    13. Oeffinger KC
    14. Hudson MM
    15. Armstrong GT
    Major cardiac events for adult survivors of childhood cancer diagnosed between 1970 and 1999: report from the Childhood Cancer Survivor Study cohort; BMJ; Vol 368. 2020 Jan 01.
    1. Andolina JR
    Reexamining 1-Gene Deletion α-Thalassemia: Is the Silent Carrier of Clinical Significance?; Acta haematologica. 2019 Nov 27.
    1. Athale U
    2. Hijiya N
    3. Patterson BC
    4. Bergsagel J
    5. Andolina JR
    6. Bittencourt H
    7. Schultz KR
    8. Burke MJ
    9. Redell MS
    10. Kolb EA
    11. Johnston DL
    Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group.; Pediatric blood & cancer; Vol 66(9). 2019 Sep.
    1. Chi AS
    2. Tarapore RS
    3. Hall MD
    4. Shonka N
    5. Gardner S
    6. Umemura Y
    7. Sumrall A
    8. Khatib Z
    9. Mueller S
    10. Kline C
    11. Zaky W
    12. Khatua S
    13. Weathers SP
    14. Odia Y
    15. Niazi TN
    16. Daghistani D
    17. Cherrick I
    18. Korones D
    19. Karajannis MA
    20. Kong XT
    21. Minturn J
    22. Waanders A
    23. Arillaga-Romany I
    24. Batchelor T
    25. Wen PY
    26. Merdinger K
    27. Schalop L
    28. Stogniew M
    29. Allen JE
    30. Oster W
    31. Mehta MP
    Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201.; Journal of neuro-oncology; Vol 145(1), pp. 97-105. 2019 Aug 27.
    1. Blumberg N
    2. Cholette JM
    3. Cahill C
    4. Pietropaoli AP
    5. Winters S
    6. Phipps R
    7. Noronha SA
    8. Heal JM
    9. Kirkley SA
    10. Fountaine TJ
    11. Henrichs K
    12. Masel D
    13. Refaai MA
    Transfusion medicine: A research agenda for the coming years.; Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 2019 Aug 06.
    1. Calvi LM
    2. Frisch BJ
    3. Kingsley PD
    4. Koniski AD
    5. Love TM
    6. Williams JP
    7. Palis J
    Acute and late effects of combined internal and external radiation exposures on the hematopoietic system.; International journal of radiation biology. 2019 Jul 30.
    1. Binkley MS
    2. Brady JL
    3. Hajj C
    4. Chelius M
    5. Chau K
    6. Balogh A
    7. Levis M
    8. Filippi AR
    9. Jones M
    10. Ahmed S
    11. MacManus M
    12. Wirth A
    13. Oguchi M
    14. Vistisen AK
    15. Andraos TY
    16. Ng AK
    17. Aleman BMP
    18. Choi SH
    19. Kirova YM
    20. Hardy S
    21. Reinartz G
    22. Eich HT
    23. Bratman SV
    24. Constine LS
    25. Suh CO
    26. Dabaja B
    27. El-Galaly TC
    28. Hodgson DC
    29. Ricardi U
    30. Yahalom J
    31. Mikhaeel NG
    32. Hoppe RT
    Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG.; International journal of radiation oncology, biology, physics; Vol 104(3). 2019 Jul 01.
    1. Usmani S
    2. Sivagnanalingam U
    3. Tkachenko O
    4. Nunez L
    5. Shand JC
    6. Mullen CA
    Support of acute lymphoblastic leukemia cells by nonmalignant bone marrow stromal cells.; Oncology letters; Vol 17(6). 2019 Jun.
    1. Bates JE
    2. Howell RM
    3. Liu Q
    4. Yasui Y
    5. Mulrooney DA
    6. Dhakal S
    7. Smith SA
    8. Leisenring WM
    9. Indelicato DJ
    10. Gibson TM
    11. Armstrong GT
    12. Oeffinger KC
    13. Constine LS
    Therapy-Related Cardiac Risk in Childhood Cancer Survivors: An Analysis of the Childhood Cancer Survivor Study.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology; Vol 37(13). 2019 May 01.
    1. Frisch BJ
    2. Hoffman CM
    3. Latchney SE
    4. LaMere MW
    5. Myers J
    6. Ashton J
    7. Li AJ
    8. Saunders J
    9. Palis J
    10. Perkins AS
    11. McCabe A
    12. Smith JN
    13. McGrath KE
    14. Rivera-Escalera F
    15. McDavid A
    16. Liesveld JL
    17. Korshunov VA
    18. Elliott MR
    19. MacNamara KC
    20. Becker MW
    21. Calvi LM
    Aged marrow macrophages expand platelet-biased hematopoietic stem cells via Interleukin1B.; JCI insight; Vol 5. 2019 Apr 18.
    1. Jabbour SK
    2. Timmerman RD
    3. Raben D
    4. DeWeese TL
    5. Donaldson SS
    6. Thomas P
    7. Laurie F
    8. Bishop-Jodoin M
    9. Tarbell N
    10. Wolden S
    11. Halperin E
    12. Constine LS
    13. Haas-Kogan D
    14. Marcus K
    15. Freeman C
    16. Terezakis S
    17. Million L
    18. Smith MA
    19. Mendenhall NP
    20. Marcus RB
    21. Cherlow J
    22. Kalapurakal J
    23. Breneman J
    24. Yock T
    25. MacDonald S
    26. Laack N
    27. Donahue B
    28. Indelicato D
    29. Michalski J
    30. Perkins S
    31. Kachnic L
    32. Esiashvilli N
    33. Roberts KB
    34. FitzGerald TJ
    Moody D. Wharam Jr, MD, FACR, FASTRO, July 22, 1941-August 10, 2018.; International journal of radiation oncology, biology, physics; Vol 103(5). 2019 Apr 01.
    1. Constine LS
    2. Ronckers CM
    3. Hua CH
    4. Olch A
    5. Kremer LCM
    6. Jackson A
    7. Bentzen SM
    Pediatric Normal Tissue Effects in the Clinic (PENTEC): An International Collaboration to Analyse Normal Tissue Radiation Dose-Volume Response Relationships for Paediatric Cancer Patients.; Clinical oncology (Royal College of Radiologists (Great Britain)); Vol 31(3). 2019 Mar.
    1. Kizilyer A
    2. Singh MV
    3. Singh VB
    4. Suwunnakorn S
    5. Palis J
    6. Maggirwar SB
    Inhibition of Tropomyosin Receptor Kinase A Signaling Negatively Regulates Megakaryopoiesis and induces Thrombopoiesis.; Scientific reports; Vol 9(1). 2019 Feb 26.
    1. Chirico J
    2. Donnelly JP
    3. Gupton A
    4. Cromwell P
    5. Miller M
    6. Dawson C
    7. Korones DN
    Costs of Care and Location of Death in Community-Based Pediatric Palliative Care.; Journal of palliative medicine; Vol 22(5), pp. 517-521. 2019 Feb 07.
    1. Andolina JR
    2. Burke MJ
    3. Hijiya N
    4. Chaudhury S
    5. Schultz KR
    6. Roth ME
    Practice Patterns of Physician Treatment for Pediatric Chronic Myelogenous Leukemia.; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation; Vol 25(2). 2019 Feb.
    1. Hilt ZT
    2. Pariser DN
    3. Ture SK
    4. Mohan A
    5. Quijada P
    6. Asante A
    7. Cameron SJ
    8. Sterling JA
    9. Merkel AR
    10. Johanson AL
    11. Jenkins JL
    12. Small EM
    13. McGrath KE
    14. Palis J
    15. Elliott MR
    16. Morrell CN
    Platelet-derived β2M regulates monocyte inflammatory responses.; JCI insight. 2019 Jan 31.
    1. Orgel E
    2. Alexander TB
    3. Wood BL
    4. Kahwash SB
    5. Devidas M
    6. Dai Y
    7. Alonzo TA
    8. Mullighan CG
    9. Inaba H
    10. Hunger SP
    11. Raetz EA
    12. Gamis AS
    13. Rabin KR
    14. Carroll AJ
    15. Heerema NA
    16. Berman JN
    17. Woods WG
    18. Loh ML
    19. Zweidler-McKay PA
    20. Horan JT
    Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force.; Cancer; Vol 126(3), pp. 593-601. 2019 Jan 29.
    1. Stolla MC
    2. Catherman SC
    3. Kingsley PD
    4. Rowe RG
    5. Koniski AD
    6. Fegan K
    7. Vit L
    8. McGrath KE
    9. Daley GQ
    10. Palis J
    Lin28b regulates age-dependent differences in murine platelet function.; Blood advances; Vol 3(1). 2019 Jan 08.
    1. Mulu Fentie A
    2. Buhlinger K
    3. Borlagdan J
    4. Bernstein A
    5. Weitzman S
    6. Bekele W
    7. Korones D
    8. Alexander TB
    9. Broas J
    10. Shad A
    11. Mamude Dinkiye A
    12. Hailu D
    13. Muluneh B
    Pre-implementation assessment of a national Ethiopian pediatric cancer registry.; Blood advances; Vol 3(Suppl 1), pp. 16-19. 2019 Jan 06.
    1. Nickel RS
    2. Horan JT
    3. Abraham A
    4. Qayed M
    5. Haight A
    6. Ngwube A
    7. Liang H
    8. Luban NLC
    9. Hendrickson JE
    Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell disease.; British journal of haematology; Vol 189(1), pp. 162-170. 2019 Jan 01.
    1. Khan F
    2. Williams AM
    3. Weiner DJ
    4. Constine LS
    Impact of respiratory developmental stage on sensitivity to late effects of radiation in pediatric cancer survivors.; Adv Radiat Oncol; Vol 5(3), pp. 426-433. 2019 Jan 01.
    1. Brady JL
    2. Binkley MS
    3. Hajj C
    4. Chelius M
    5. Chau K
    6. Balogh A
    7. Levis M
    8. Filippi AR
    9. Jones M
    10. Mac MM
    11. Wirth A
    12. Oguchi M
    13. Vistisen AK
    14. Andraos TY
    15. Ng AK
    16. Aleman B
    17. Choi SH
    18. Kirova Y
    19. Hardy S
    20. Reinartz G
    21. Eich HT
    22. Bratman SV
    23. Constine LS
    24. Suh CO
    25. Dabaja B
    26. El-Galaly TC
    27. Hodgson DC
    28. Ricardi U
    29. Yahalom J
    30. Hoppe RT
    31. Mikhaeel NG
    Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG; Blood; Vol 133(3), pp. 237-245. 2019 Jan 01.
    1. Al-Mansour Z
    2. Li H
    3. Cook JR
    4. Constine LS
    5. Couban S
    6. Stewart DA
    7. Shea TC
    8. Porcu P
    9. Winter JN
    10. Kahl BS
    11. Smith SM
    12. Marcellus DC
    13. Barton KP
    14. Mills GM
    15. LeBlanc M
    16. Rimsza LM
    17. Forman SJ
    18. Leonard JP
    19. Fisher RI
    20. Friedberg JW
    21. Stiff PJ
    Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis; Leukemia & Lymphoma; Vol 60(8), pp. 1934-1941. 2019 Jan 01.
    1. FitzGerald TJ
    2. Donaldson SS
    3. Wharam M
    4. Laurie F
    5. Bishop-Jodoin M
    6. Moni J
    7. Tarbell N
    8. Shulkin B
    9. McCarville E
    10. Merchant T
    11. Krasin M
    12. Wolden S
    13. Halperin E
    14. Constine LS
    15. Haas-Kogan D
    16. Marcus K
    17. Freeman C
    18. Wilson JF
    19. Hoppe R
    20. Cox J
    21. Terezakis S
    22. Million L
    23. Smith MA
    24. Mendenhall NP
    25. Marcus RB
    26. Cherlow J
    27. Kalapurakal J
    28. Breneman J
    29. Yock T
    30. MacDonald S
    31. Laack N
    32. Donahue B
    33. Indelicato D
    34. Michalski J
    35. Perkins S
    36. Kachnic L
    37. Choy H
    38. Braunstein S
    39. Esiashvilli N
    40. Roberts KB
    Larry Emanuel Kun, March 10, 1946-May 27, 2018.; International journal of radiation oncology, biology, physics; Vol 103(1). 2019 Jan 01.
    1. Clemens E
    2. van den Heuvel-Eibrink MM
    3. Mulder RL
    4. Kremer LCM
    5. Hudson MM
    6. Skinner R
    7. Constine LS
    8. Bass JK
    9. Kuehni CE
    10. Langer T
    11. van Dalen EC
    12. Bardi E
    13. Bonne NX
    14. Brock PR
    15. Brooks B
    16. Carleton B
    17. Caron E
    18. Chang KW
    19. Johnston K
    20. Knight K
    21. Nathan PC
    22. Orgel E
    23. Prasad PK
    24. Rottenberg J
    25. Scheinemann K
    26. de Vries ACH
    27. Walwyn T
    28. Weiss A
    29. Am Zehnhoff-Dinnesen A
    30. Cohn RJ
    31. Landier W
    Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium.; The Lancet. Oncology; Vol 20(1). 2019 Jan.
    1. Noronha SA
    Aplastic and Hypoplastic Anemias.; Pediatrics in review; Vol 39(12), pp. 601-611. 2018 Dec.
    1. Yien YY
    2. Shi J
    3. Chen C
    4. Cheung JT
    5. Grillo AS
    6. Shrestha R
    7. Li L
    8. Zhang X
    9. Kafina MD
    10. Kingsley PD
    11. King MJ
    12. Ablain J
    13. Li H
    14. Zon L
    15. Palis J
    16. Burke MD
    17. Bauer DE
    18. Orkin SH
    19. Koehler CM
    20. Phillips JD
    21. Kaplan J
    22. Ward DM
    23. Lodish HF
    24. Paw BH
    FAM210B is an erythropoietin target and regulates erythroid heme synthesis by controlling mitochondrial iron import and ferrochelatase activity.; The Journal of biological chemistry. 2018 Oct 26.
    1. Ayoub E
    2. Wilson MP
    3. McGrath KE
    4. Li AJ
    5. Frisch BJ
    6. Palis J
    7. Calvi LM
    8. Zhang Y
    9. Perkins AS
    EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription.; Nature communications; Vol 9(1). 2018 Oct 12.
    1. Allen CE
    2. Marsh R
    3. Dawson P
    4. Bollard CM
    5. Shenoy S
    6. Roehrs P
    7. Hanna R
    8. Burroughs L
    9. Kean L
    10. Talano JA
    11. Schultz KR
    12. Pai SY
    13. Baker KS
    14. Andolina JR
    15. Stenger EO
    16. Connelly J
    17. Ramirez A
    18. Bryant C
    19. Eapen M
    20. Pulsipher MA
    Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies.; Blood; Vol 132(13). 2018 Sep 27.
    1. Woolfrey A
    2. Wang T
    3. Lee SJ
    4. Haagenson MD
    5. Chen G
    6. Fleischhauer K
    7. Horan J
    8. Hsu K
    9. Verneris M
    10. Spellman SR
    11. Fernandez-Vina M
    Donor-specific anti-HLA antibodies in unrelated hematopoietic cell transplantation for non-malignant disorders.; Bone marrow transplantation; Vol 54(3), pp. 494-496. 2018 Sep 19.
    1. Alexander TB
    2. Gu Z
    3. Iacobucci I
    4. Dickerson K
    5. Choi JK
    6. Xu B
    7. Payne-Turner D
    8. Yoshihara H
    9. Loh ML
    10. Horan J
    11. Buldini B
    12. Basso G
    13. Elitzur S
    14. de Haas V
    15. Zwaan CM
    16. Yeoh A
    17. Reinhardt D
    18. Tomizawa D
    19. Kiyokawa N
    20. Lammens T
    21. De Moerloose B
    22. Catchpoole D
    23. Hori H
    24. Moorman A
    25. Moore AS
    26. Hrusak O
    27. Meshinchi S
    28. Orgel E
    29. Devidas M
    30. Borowitz M
    31. Wood B
    32. Heerema NA
    33. Carrol A
    34. Yang YL
    35. Smith MA
    36. Davidsen TM
    37. Hermida LC
    38. Gesuwan P
    39. Marra MA
    40. Ma Y
    41. Mungall AJ
    42. Moore RA
    43. Jones SJM
    44. Valentine M
    45. Janke LJ
    46. Rubnitz JE
    47. Pui CH
    48. Ding L
    49. Liu Y
    50. Zhang J
    51. Nichols KE
    52. Downing JR
    53. Cao X
    54. Shi L
    55. Pounds S
    56. Newman S
    57. Pei D
    58. Guidry Auvil JM
    59. Gerhard DS
    60. Hunger SP
    61. Inaba H
    62. Mullighan CG
    The genetic basis and cell of origin of mixed phenotype acute leukaemia.; Nature; Vol 562(7727), pp. 373-379. 2018 Sep 12.
    1. Azzoni E
    2. Frontera V
    3. McGrath KE
    4. Harman J
    5. Carrelha J
    6. Nerlov C
    7. Palis J
    8. Jacobsen SEW
    9. de Bruijn MF
    Kit ligand has a critical role in mouse yolk sac and aorta-gonad-mesonephros hematopoiesis.; EMBO reports. 2018 Aug 30.
    1. Keller FG
    2. Castellino SM
    3. Chen L
    4. Pei Q
    5. Voss SD
    6. McCarten KM
    7. Senn SL
    8. Buxton AB
    9. Bush R
    10. Constine LS
    11. Schwartz CL
    Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: A report from the Children's Oncology Group.; Cancer; Vol 124(15). 2018 Aug 01.
    1. Okunieff P
    2. Casey-Sawicki K
    3. Lockney NA
    4. Hoppe BS
    5. Enderling H
    6. Pinnix C
    7. Welsh J
    8. Krishnan S
    9. Yothers G
    10. Brown M
    11. Knox S
    12. Bristow R
    13. Spellman P
    14. Mitin T
    15. Nabavizadeh N
    16. Jaboin J
    17. Manning HC
    18. Feng F
    19. Galbraith S
    20. Solanki AA
    21. Harkenrider MM
    22. Tuli R
    23. Decker RH
    24. Finkelstein SE
    25. Hsu CC
    26. Ha CS
    27. Jagsi R
    28. Shumway D
    29. Daly M
    30. Wang TJC
    31. Fitzgerald TJ
    32. Laurie F
    33. Marshall DT
    34. Raben D
    35. Constine L
    36. Thomas CR
    37. Kachnic LA
    Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017.; Clinical cancer research : an official journal of the American Association for Cancer Research; Vol 24(15). 2018 Aug 01.
    1. Landier W
    2. Skinner R
    3. Wallace WH
    4. Hjorth L
    5. Mulder RL
    6. Wong FL
    7. Yasui Y
    8. Bhakta N
    9. Constine LS
    10. Bhatia S
    11. Kremer LC
    12. Hudson MM
    Surveillance for Late Effects in Childhood Cancer Survivors.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology; Vol 36(21). 2018 Jul 20.
    1. Kenney LB
    2. Antal Z
    3. Ginsberg JP
    4. Hoppe BS
    5. Bober SL
    6. Yu RN
    7. Constine LS
    8. van Santen HM
    9. Skinner R
    10. Green DM
    Improving Male Reproductive Health After Childhood, Adolescent, and Young Adult Cancer: Progress and Future Directions for Survivorship Research.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology; Vol 36(21). 2018 Jul 20.
    1. Chow EJ
    2. Antal Z
    3. Constine LS
    4. Gardner R
    5. Wallace WH
    6. Weil BR
    7. Yeh JM
    8. Fox E
    New Agents, Emerging Late Effects, and the Development of Precision Survivorship.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology; Vol 36(21). 2018 Jul 20.
    1. Breneman JC
    2. Donaldson SS
    3. Constine L
    4. Merchant T
    5. Marcus K
    6. Paulino AC
    7. Followill D
    8. Mahajan A
    9. Laack N
    10. Esiashvili N
    11. Haas-Kogan D
    12. Laurie F
    13. Olch A
    14. Ulin K
    15. Hodgson D
    16. Yock TI
    17. Terezakis S
    18. Krasin M
    19. Panoff J
    20. Chuba P
    21. Hua CH
    22. Hess CB
    23. Houghton PJ
    24. Wolden S
    25. Buchsbaum J
    26. Fitzgerald TJ
    27. Kalapurakal JA
    The Children's Oncology Group Radiation Oncology Discipline: 15 Years of Contributions to the Treatment of Childhood Cancer.; International journal of radiation oncology, biology, physics; Vol 101(4). 2018 Jul 15.
    1. O'Dwyer K
    2. Freyer DR
    3. Horan JT
    Treatment strategies for adolescent and young adult patients with acute myeloid leukemia.; Blood; Vol 132(4), pp. 362-368. 2018 Jun 12.
    1. Farris N
    2. Wu H
    3. Said-Delgado S
    4. Suskin B
    5. Klugman S
    17p13.3 quadruplication: a prenatal and postpartum clinical characterization of a copy number variant.; Cold Spring Harbor molecular case studies; Vol 4(3). 2018 Jun 01.

More About Pediatric Hematology Oncology Investigators